Breast Cancer pp 129-144 | Cite as

Radiation Therapy

  • Barbara Fowble
  • Gary Freedman
Part of the Current Clinical Oncology book series (CCO)


Radiotherapy has played an important role in the treatment of breast cancer. It is frequently given following conservative surgery for ductal carcinoma in situ (DCIS) or stage I and II invasive breast cancer. Its role as adjuvant therapy following mastectomy in selected patients with stage I and II disease is currently being defined, and it is an essential component of the combined modality approach for stage III disease. Radiation represents an important therapeutic option for the palliation of metastases to sites such as bone and brain and may be used alone or in combination with surgery to control recurrent disease in the chest wall or regional nodes following mastectomy. This chapter discusses the role of radiation in the treatment of DCIS, stage I and II breast cancer, locally advanced breast cancer, local-regional recurrence, and metastatic disease (Table 1).


Breast Cancer Axillary Dissection Contralateral Breast Cancer Conservative Surgery Breast Conservation Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arriagada R, Le MG, Rochard F, Contesso G, for the Institut Gustave-Roussy Breast Cancer Group (1996) Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. J. Clin. Oncol. 14, 1558–1564.PubMedGoogle Scholar
  2. Blichert-Toft M, Rose C, Andersen JA, et al. (1992) Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis, Danish Breast Cancer Cooperative Group. Monogr. Natl. Cancer Inst. 11, 19–25.PubMedGoogle Scholar
  3. Bartelink H, Horiot JC, Poortmans P, et al. (2001) Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N. Engl. J. Med. 345, 1378–1387.PubMedCrossRefGoogle Scholar
  4. Bijker N, Peterse JL, Duchateau L, et al. (2001) Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853. J. Clin. Oncol. 19, 2263–2271.PubMedGoogle Scholar
  5. Bonadonna G, Valagussa P, Brambilla C, et al. (1998) Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. J. Clin. Oncol. 16, 93–100.PubMedGoogle Scholar
  6. Clark RM, Whelan T, Levine M, et al. (1996) Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. J. Natl. Cancer Inst. 88, 1659–1664.PubMedCrossRefGoogle Scholar
  7. Coia LR, Aaronson N, Linggood R, et al. (1996) A report of the consensus workshop panel on the treatment of brain metastases. Int. J. Radiat. Oncol. Biol. Phys. 23, 223–227.CrossRefGoogle Scholar
  8. Danforth Jr DN, Zujewski J, O’Shaughnessy J, et al. (1998) Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer. Ann. Surg. Oncol. 5, 150–158.PubMedCrossRefGoogle Scholar
  9. Early Breast Cancer Trialists’ Collaborative Group (2000) Favorable and unfavorable effects on long-term sur- vival of radiotherapy of early breast cancer: an overview of the randomised trials. Lancet 335, 1757–1770.Google Scholar
  10. Fisher B, Dignam J, Wolmark N, et al. (1999) Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 353, 1993–2000.PubMedCrossRefGoogle Scholar
  11. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM (1995a) Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N. Engl. J. Med. 333, 1456–1461.PubMedCrossRefGoogle Scholar
  12. Fisher B, Dignam J, Wolmark N, et al. (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from the National Surgical Adjuvant Breast and Bowel Project B-17. J. Clin. Oncol. 16, 441–452.PubMedGoogle Scholar
  13. Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E (1995b) Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). Cancer 75, 1310–1319.PubMedCrossRefGoogle Scholar
  14. Fleming RYD, Asmar L, Buzdar AU, et al. (1997) Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma. Ann. Surg. Oncol. 4, 452–461.PubMedCrossRefGoogle Scholar
  15. Forrest AP, Stewart HJ, Everington D, on behalf of Scottish Cancer Trials Breast Group (1996) Randomized controlled trial of conservation therapy for breast cancer: 6 year analysis of the Scottish trial. Lancet 348, 708–713.PubMedCrossRefGoogle Scholar
  16. Fowble B (1997) Postmastectomy radiation: then and now. Oncology 11, 213–239.PubMedGoogle Scholar
  17. Fowble B, Glover D (1991) Locally advanced breast cancer. In: Fowble B, Goodman RL, Glick JH, Rosato EF (eds.) Breast Cancer Treatment. A Comprehensive Guide to Management. Mosby-Year Book, St. Louis, MO, pp. 345–372.Google Scholar
  18. Fowble B, Gray R, Gilchrist K, et al. (1988) Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J. Clin. Oncol. 6, 1107–1117.PubMedGoogle Scholar
  19. Fowble B, Hanlon AL, Fein DA, et al. (1997) Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS). Int. J. Radiat. Oncol. Biol. Phys. 38, 949–957.PubMedCrossRefGoogle Scholar
  20. Freedman GM, Fowble BL, Hanlon AL, et al. (1997) Postmastectomy radiation and adjuvant systemic therapy: outcomes in high-risk women with stage II-III breast cancer and assessment of clinical, pathologic, and treatment-related factors influencing local-regional control. Breast J. 3, 337–344.CrossRefGoogle Scholar
  21. Gaspar L, Scott C, Rotman M, et al. (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int. J. Radiat. Oncol. Biol. Phys. 37, 745–751.PubMedCrossRefGoogle Scholar
  22. Hughes KS, Schnaper L, Berry D, et al. (2001) Comparison of lumpectomy plus tamoxifen with or without radiotherapy in women 70 years of age or older who have clinical stage I, estrogen receptor positive breast carcinoma. Proc. Am. Soc. Clin. Oncol. 20, 24a (abst.).Google Scholar
  23. Jacobson JA, Danforth DN, Cowan KH, et al. (1995) Ten year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N. Engl. J. Med. 332, 907–911.PubMedCrossRefGoogle Scholar
  24. Liljegren G, Holmberg L, Bergh J, et al. (1999) 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: A randomized trial. J. Clin. Oncol. 17, 2326–2333.PubMedGoogle Scholar
  25. Loblaw DA, and Laperriere NJ (1998) Emergency treatment of malignant extradural spinal cord compression: an evidence-based guideline. J. Clin. Oncol. 16, 1613–1624.PubMedGoogle Scholar
  26. National Comprehensive Cancer Network (1999) Practice guidelines for the treatment of breast cancer. Oncology 13, 41–66.Google Scholar
  27. Overgaard M, Hansen PS, Overgaard J, et al. (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N. Engl. J. Med. 337, 949–955.PubMedCrossRefGoogle Scholar
  28. Perez CA, Fields JN, Fracasso PM, et al. (1994) Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma. Cancer 74, 466–476.PubMedCrossRefGoogle Scholar
  29. Ragaz J, Jackson S, Le M, et al. (1999) Postmastectomy radiation outcome in node positive breast cancer patients among N1–3 versus N4 and subset: impact of extracapsular spread. Update of the British Columbia randomized trial. Proc. Am. Soc. Clin. Oncol. 18, 73a.Google Scholar
  30. Ragaz J, Jackson SM, Nhu L, et al. (1997) Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N. Engl. J. Med. 337, 956–962.PubMedCrossRefGoogle Scholar
  31. Recht A, Bartelink H, Fourquet A, et al. (1998) Postmastectomy radiotherapy: questions for the twenty-first century. J. Clin. Oncol. 16, 2886–2889.PubMedGoogle Scholar
  32. Recht A, Come SE, Henderson IC, et al. (1996) The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N. Engl. J. Med. 334, 1356–1361.PubMedCrossRefGoogle Scholar
  33. Renton SC, Gazet J-C, Ford HT, Corbishley C, Sutcliffe R (1996) The importance of the resection margin in conservative surgery for breast cancer. Eur. J. Surg. Oncol. 22, 17–22.PubMedCrossRefGoogle Scholar
  34. Romestaing P, Lehingue Y, Carrie C, et al. (1997) Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France. J. Clin. Oncol. 15, 963–968.PubMedGoogle Scholar
  35. Rutqvist LE, Cedermark B, Glas U, et al. (1990) Randomized trial of adjuvant tamoxifen combined with postoperative radiotherapy or adjuvant chemotherapy in postmenopausal breast cancer. Cancer 66, 89–96.PubMedCrossRefGoogle Scholar
  36. Silverstein MJ (1997) Ductal Carcinoma In Situ of the Breast. Williams & Wilkins, Baltimore.Google Scholar
  37. Solin LJ, Kurtz J, Fourquet A, et al. (1996a) Fifteen year results of breast conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ (intraductal carcinoma of the breast). J. Clin. Oncol. 14, 754–763.PubMedGoogle Scholar
  38. Solin LJ, Fourquet A, Vicini FA, et al. (2001) Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. Int. J. Radia. Oncol. Biol. Phys. 50, 991–2001.CrossRefGoogle Scholar
  39. Tennrall-Nittby L, Tengrup J, Landberg T (1993) The total incidence of loco-regional recurrence in a randomized trial of breast cancer TNM stage II. The South Sweden Breast Cancer Trial. Acta Oncol. 32, 641–646.CrossRefGoogle Scholar
  40. Tong D, Gillick L, Hendrickson FR (1982) The palliation of symptomatic osseous metastases. Final results of the study by the Radiation Therapy Oncology Group. Cancer 50, 893–899.PubMedCrossRefGoogle Scholar
  41. Valagussa P, Zambetti M, Bonadonna G, et al. (1990) Prognostic factors in locally advanced noninflammatory breast cancer. Long term results following primary chemotherapy. Breast Cancer Res. Treat. 15, 137–147.PubMedCrossRefGoogle Scholar
  42. van Dongen JA, Voogd AD, Fentiman IS, et al. (2000) Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J. Natl. Cancer Inst. 92, 1143–1150.PubMedCrossRefGoogle Scholar
  43. Veronesi U, Marubini E, Mariani L, et al. (2001) Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol. 12, 997–1003.PubMedCrossRefGoogle Scholar
  44. Veronesi U, Salvadori B, Luini A, et al. (1995) Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomized trials on 1973 patients. Eur. J. Cancer 31A, 1574–1579.CrossRefGoogle Scholar
  45. Winchester DP, JD C (1998) Standards for diagnosis and management of invasive breast carcinoma. CA Cancer J. Clin. 48, 83–107.PubMedCrossRefGoogle Scholar
  46. Winchester DP, Strom EA (1998) Standards for diagnosis and management of ductal carcinoma in situ (DCIS) of the breast. CA Cancer J. Clin. 48, 108–128.PubMedCrossRefGoogle Scholar
  47. Wolmark N, Dignam J, Fisher B (1998) The addition of tamoxifen to lumpectomy and radiotherapy in the treatment of ductal carcinoma in situ (DCIS): preliminary results of NSABP Protocol B-24. Breast Cancer Res. Treat. 50, 227.Google Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Barbara Fowble
  • Gary Freedman

There are no affiliations available

Personalised recommendations